Fibromyalgia Syndrome. Fibromyalgia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Both male and female patients Age over 18 years and under 60 years Pre diagnosed patients with FMS referred through consultant Manifesting chronic widespread musculoskeletal pain symptoms Presence of active trigger points, as confirmed by physical examination Willing and able to provide informed consent to participate in the study. Ability to understand and comply with the study requirements No contraindications to dry needling or IMS
Exclusion criteria
Exclusion criteria: Pregnancy or breastfeeding Use of any medications that could interfere with the study results (e.g. muscle relaxants, opioids) within the past 48 hours. Previous treatment with dry needling or IMS within the past 6 months Presence of any other conditions that could interfere with the study results (e.g. cancer, infection) Participation in any other clinical trials within the past 30 days Anatomical anomaly Structural disorder of spinal alignment (Scoliosis, kyphosis, lordosis)o Any bone abnormality in neck region Traumatic/ Inflammatory/ Infectious Conditions such as Recent Trauma, Nerve root compromise, Metabolic or serious spinal pathologies (e.g., fractures, tumors, inflammatory, and infectious diseases), Previous neck surgery Psycho-social Instability such as Diagnosed stress/ depression/ Anxiety Risk Profile such as High Risk Inability to understand or comply with the study requirements, as determined by the physiotherapist
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Baseline screening, Assessment at 2nd week interval, Assessment at 4th week interval, Follow up at 8th week interval. Method of measurement: Numeric Pain Rating Scale.;Pressure. Timepoint: Baseline screening, Assessment at 2nd week interval, Assessment at 4th week interval, Follow up at 8th week interval. Method of measurement: Pain pressure threshold; algometer.;Anxiety depression. Timepoint: Baseline screening, Assessment at 2nd week interval, Assessment at 4th week interval, Follow up at 8th week interval. Method of measurement: Hospital Anxiety and Depression Scale (HADS).;Quality of Sleep. Timepoint: Baseline screening, Assessment at 2nd week interval, Assessment at 4th week interval, Follow up at 8th week interval. Method of measurement: Pittsburgh Sleep Quality Index (PSQI).;Fatigue. Timepoint: Baseline screening, Assessment at 2nd week interval, Assessment at 4th week interval, Follow up at 8th week interval. Method of measurement: Multidimensional Fatigue Inventory (MFI). | — |
Countries
Pakistan
Contacts
The University of Lahore